Look Who's Coming to the MassBio Investors Forum

September 24, 2009

Investors Forum

LOOK WHO'S COMING TO THE MassBio INVESTORS FORUM

Don't miss this opportunity to meet colleagues, strategic partners, potential investors... Register today and use our partnering software to request one-on-one meetings!

For a full agenda of the event, click here.

Delegates from the following companies will attend:

Accelerated Cure Project for Multiple Sclerosis
Agios Pharmaceuticals
Airgas, Inc.
Alfama
Alnylam Pharmaceuticals, Inc.
Alsace BioValley
Alseres Pharmaceuticals, Inc.
American Cancer Society, New England Division, Inc.
Anglo Irish Bank
Antigen Express, Inc.
Aptuit Consulting, Inc.
Ascent Therapeutics, Inc.
Averion International Corp.
Avila Therapeutics, Inc
Babson Executive Education
Belgium-Wallonia Trade & Investment
Bentley University
BG Medicine, Inc.
Bilcare, Inc.
BioRealty, Inc.
BIOTECanada
BioVex, Inc.
Cancer Research Technology Inc.
Celator Pharmaceuticals, Inc.
Center for Performance Investing
Cequent Pharmaceuticals, Inc.
Communications Strategy Group Inc.
CoNCERT Pharmaceuticals, Inc.
Constellation Pharmaceuticals Inc.
CORFO-ASEMBIO
Debt Advisors Group
Dicerna Pharmaceuticals, Inc.
EMD Serono, Inc.
EnVivo Pharmaceuticals, Inc.
Eutropics Pharmaceuticals Inc.
Exponential Pharma Ventures
Eyegate Pharmaceuticals Inc.
Faber Daeufer & Rosenberg PC
Flagship Ventures
Forest City Commercial Group
Forma Therapeutics
Galenea Corp.
GE Commercial Finance Healthcare Financial Services
Genzyme Corporation
GlaxoSmithKline
Goodwin Procter LLP
Greenberg Traurig, LLP
Halloran Consulting Group, Inc.
Harvard Medical School
Health Advances LLC
Health Enterprise East
Hepregen Corporation
IDA Ireland
Idera Pharmaceuticals
incTANK ventures
Inotek Pharmaceuticals Corporation
Integrated Project Management Company, Inc.
inVentiv Clinical Solutions
Ironwood Pharmaceuticals, Inc.
Johnson & Johnson Development Corporation
Joslin Diabetes Research Center
Juvenile Diabetes Research Foundation
Kyorin USA Inc.
Liberty Tree Advisors, LLC
Life Science Advisors
Lilly BioVentures
Logical Therapeutics, Inc.
Lumira Capital
Lyon Bio Pole
MA2 (Mass Med Angels)
Massachusetts General Hospital
MassBioLogics
MassDevelopment
MedImmune, Inc.
Merck & Co., Inc.
Mersana Therapeutics, Inc.
MicroCHIPS, Inc.
Microtest Laboratories, Inc.
MP Healthcare Venture Management, Inc.
MPM Capital
National Brain Tumor Society
NeoMed
Nixon Peabody LLP
Northeastern University
Novartis
NYCOMED
ORA Clinical Research and Development
Oxford Contrast Molecular Diagniostics
Partners HealthCare System, Inc.
Partners Venture Fund
PCI Synthesis
PERCIVIA LLC
Pfizer, Inc. Research Technology Center
pION INC
Polaris Venture Partners
PricewaterhouseCoopers, LLP
Prism VentureWorks
Puretech Ventures
PX'Therapeutics
Quebec Delegation
RainDance Technologies, Inc.
Regis Duffy Bioscience Fund Inc.
Sanofi Aventis Pharmaceuticals, Cambridge Research Center
Sepracor, Inc.
Shawmut Design and Construction
Silicon Valley Bank
Spring Bank Technologies, Inc. (SBT)
SR One Ltd
Stem Cell Capital
Stromedix
Taligen Therapeutics
Targeted Cell Therapies
The GI Company, Inc.
The Pine Cone Company
Tolerx, Inc.
TransForm Pharmaceuticals, Inc.
TransMolecular, Inc.
TriNet
TVM Capital
Voisin Consulting, Inc.
WilmerHale
Wolf, Greenfield & Sacks, P.C.
Wolfe Laboratories, Inc.

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Upcoming Events email!
For Email Marketing you can trust

MassBio